Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

Cardiovascular diseases (CVDs) are the key factors leading to death and disability worldwide. This severe challenge has prompted the scientific research and ...

A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with international partners, has designed a strategy for preventing the cardiotoxic ...

A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with ...

In support of its mission, the GCRFF is proud to launch the International Research Challenge (IRC) on Women’s Cardiovascular Health. This first of its kind network grant aims to fund the best science ...

Established in 1974, the Master of Arts program in Dance/Movement Therapy and Counseling educates students for creative, responsive and effective therapy practice. This unique program addresses both ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Cell & gene therapy stands at the forefront of modern medicine ... the continued use of non-physiological O 2 levels could be stifling our efforts to conduct more insightful research and develop ...

Xiamen Cell Therapy Research Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China ...

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in tandem thanks to advancements in technology and a growing body of research on ...

The found that patients who responded to DLI therapy ... cell type originates in the DLI product. That is, it is present in the donor's original graft and re-infused during DLI. "The goal of our ...

STM-01 is aimed at treating severe cardiovascular ... the latter’s cellular therapy, STM-01. The collaboration will see Cellipont offering technology transfer, cGMP manufacturing and analytical method ...